drugset / Trial / NCT04736927

Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects

NCT04736927 ↗

Phase 1 Completed 14 enrolled Lakefront Biotherapeutics NV
NaSingle-groupOpen-labelBasic science

Summary

A study in healthy volunteers to look at the effect of the test medicine, GLPG3667, on how midazolam (MDZ) is taken up and eliminated by the body.

Timeline

Start
2021-01-15
Primary completion
2021-02-25
Completion
2021-02-25

Drugs

EvaluationDrugModalityDoseRoute
Subject GLPG3667 Small molecule — Oral
Subject Midazolam Small molecule — Oral

Indications

No indication recorded.